Alternatively, another study suggested that LOX-1 + receptor biomarker presented by PMN cells in peripheral blood can be used as potential additional biomarker since they demonstrated suppressive activity against T cell proliferation in tumor site [32]. The gene discussed is OLR1; the disease is neoplasm.